EUVIMEDEUVIMED entdecken
Crossref

L26/P-703 Genetic and functional evidence implicates IVD as a key driver of mitochondrial dysfunction in polycystic ovary syndrome

L. Mu, C. Lou, S. Song, Z. Wang, Z. Chen, Y. Zhao

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.1032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von L. Mu und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Do genetically predicted changes in mitochondrial gene regulation causally influence PCOS risk, and which gene mediates mitochondrial dysfunction? Summary answer Multi-omics Mendelian randomization prioritised isovaleryl-CoA dehydrogenase (IVD); reduced ovarian/granulosa-cell IVD and CRISPR IVD knockout caused oxidative stress and bioenergetic failure. What is known already Mitochondrial defects—reduced mitochondrial DNA (mtDNA) copy number, altered oxidative phosphorylation and increased reactive oxygen species (ROS)—have been repeatedly observed in PCOS tissues and granulosa cells, but most evidence is observational and the causal genes and mechanisms remain unclear. Study design, size, duration Genetic-to-functional study integrating PCOS genome-wide association study (GWAS) summary statistics (including multi-trait analysis of GWAS, MTAG) with mitochondrial quantitative trait loci (QTL) resources—protein (pQTL), DNA methylation (mQTL) and expression (eQTL) in the hypothalamus-pituitary-ovary(HPO) axis—followed by ovarian RNA-seq and granulosa-cell functional experiments. Participants/materials, setting, methods European-ancestry GWAS and QTL summary datasets were analysed using summary-data-based Mendelian randomization (SMR) with heterogeneity in dependent instruments (HEIDI) and Bayesian colocalization. Ovarian tissue RNA-seq compared 16 PCOS cases with 16 controls. Granulosa cells were collected from 25 PCOS patients and 25 controls. IVD was knocked out in KGN granulosa cells using CRISPR/Cas9; ROS, mtDNA copy number, mitochondrial ultrastructure, membrane potential and Seahorse oxygen consumption rate (OCR) / extracellular acidification rate (ECAR) were assessed. Main results and the role of chance MTAG increased the equivalent PCOS GWAS sample size from 6,507 to 36,426. In the most informative MTAG model, genetically predicted higher IVD protein abundance in blood increased PCOS susceptibility (OR = 1.21, 95% CI 1.06-1.39), and multiple IVD CpG instruments showed risk-enhancing methylation effects (e.g. cg02378269,OR=1.10; cg08129084,OR=1.05; cg20069584,OR=1.21). Pituitary eQTL instruments indicated lower PCOS risk with higher IVD expression (OR = 0.94; 95% CI, 0.89-0.98). Colocalization supported shared causal variants between IVD methylation and PCOS-related traits (PP.H4.abf >0.95). In ovarian RNA-seq, IVD expression was reduced in PCOS versus controls (P < 0.05). In primary granulosa cells, IVD was downregulated and inversely correlated with androstenedione, anti-Müllerian hormone (AMH) and antral follicle count. CRISPR/Cas9 IVD knockout in KGN cells increased ROS, lowered mtDNA copy number, disrupted mitochondrial ultrastructure and membrane potential, and reduced OCR and ECAR, consistent with bioenergetic collapse. Limitations, reasons for caution Genetic instruments and QTL resources were largely European ancestry and some QTL datasets had modest sample sizes, limiting tissue-specific resolution. Functional validation used an in vitro granulosa model and cannot fully capture systemic metabolic interactions. Wider implications of the findings IVD links branched-chain amino acid catabolism to mitochondrial dysfunction in PCOS. IVD-related molecular readouts may support mechanistic subtyping and suggest therapeutic strategies targeting bioenergetics and redox balance. Trial registration number No

Zitieren

APA

Mu, L., Lou, C., Song, S., Wang, Z., Chen, Z., & Zhao, Y. (2026). L26/P-703 Genetic and functional evidence implicates IVD as a key driver of mitochondrial dysfunction in polycystic ovary syndrome. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1032

Vancouver

Mu L, Lou C, Song S, Wang Z, Chen Z, Zhao Y. L26/P-703 Genetic and functional evidence implicates IVD as a key driver of mitochondrial dysfunction in polycystic ovary syndrome. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1032

BibTeX
@article{Mu2026,
  author = {Mu, L. and Lou, C. and Song, S. and Wang, Z. and Chen, Z. and Zhao, Y.},
  title = {L26/P-703 Genetic and functional evidence implicates IVD as a key driver of mitochondrial dysfunction in polycystic ovary syndrome},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.1032}
}
Kostenlos starten →